For decades, this medication has been prescribed to millions of patients to help regulate blood sugar levels. Considered safe, well-understood and almost routine, it has long been associated exclusively with the treatment of diabetes. Yet nearly 60 years after its introduction, researchers are uncovering surprising effects in the brain — findings that are reshaping how scientists view the drug.
A medication thought to be fully understood
When the drug first entered clinical use in the mid-20th century, its role seemed clear: improve glucose metabolism and reduce complications linked to diabetes. Over time, it became one of the most widely prescribed treatments worldwide.
Because of its long history, the medication was often regarded as “fully mapped” from a pharmacological standpoint. Few expected major discoveries to emerge so late.
A discovery that changes the narrative
Recent studies have revealed that the drug does more than act on blood sugar. Researchers observed that it crosses biological barriers previously thought irrelevant to its function and interacts with specific regions of the brain.
These interactions appear to influence:
- neuronal energy metabolism
- inflammation in brain tissue
- signaling pathways linked to memory and cognition
The findings were initially unexpected — and met with skepticism — but have since been replicated by independent teams.
What happens in the brain?
According to neuroscientists, the drug seems to affect how brain cells process energy, potentially improving their resistance to stress and aging. In laboratory models, researchers observed changes associated with:
- enhanced synaptic activity
- reduced neuroinflammation
- improved cellular resilience
While these effects do not mean the drug is a treatment for neurological diseases, they suggest a biological influence far beyond diabetes control.
Why was this discovered so late?
Experts point to several reasons:
- older drugs were studied with narrower clinical goals
- brain-related outcomes were not routinely measured decades ago
- modern imaging and molecular tools now allow deeper analysis
In other words, the technology to detect these effects simply did not exist when the drug was first developed.
“We are revisiting old medicines with new eyes,” explains one researcher. “And sometimes, they still have secrets to reveal.”
Potential implications for future research
The discovery has opened new research avenues, particularly in fields such as:
- neurodegenerative disease prevention
- cognitive aging
- metabolic–brain interactions
Some clinical trials are now exploring whether long-term use of the drug correlates with lower risks of certain neurological conditions. However, researchers stress that results are preliminary and should not be overinterpreted.
No change for patients — for now
Doctors emphasize that patients should not modify or start treatment based on these findings alone. The medication remains prescribed strictly for diabetes, and its neurological effects are still under investigation.
There is currently no recommendation to use the drug for brain-related conditions outside controlled clinical studies.
A reminder of how medicine evolves
This case illustrates an important reality of modern medicine: even well-established treatments can reveal new dimensions decades later. Drugs are not static objects; their interactions with the human body are often more complex than initially understood.
Sixty years on, this diabetes medication is no longer seen as acting solely on blood sugar — but as a reminder that scientific knowledge is never truly finished.
